Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06264297

High-Voltage Pulsed Radiofrequency of the Lumbar Dorsal Root Ganglion for the Treatment of Chronic Lumbar Radicular and Neuropathic Pain; A Prospective, Doble-blinded and Randomized Controlled Trial

Led by Consorci Sanitari de Terrassa · Updated on 2024-02-16

98

Participants Needed

1

Research Sites

249 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The management of chronic lumbar radicular and neuropathic pain is complex and the treatment success rates are low. Pulsed radiofrequency (PRF) has been described in these cases. In order to determine whether high-voltage PRF show better results than PRF a prospective, doble-blinded and randomized study is conducted in patients with chronic lumbar radicular and neuropathic pain.

CONDITIONS

Official Title

High-Voltage Pulsed Radiofrequency of the Lumbar Dorsal Root Ganglion for the Treatment of Chronic Lumbar Radicular and Neuropathic Pain; A Prospective, Doble-blinded and Randomized Controlled Trial

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients over 18 years of age.
  • Unilateral pain radiating to the lower extremity, with or without lumbar pain, matching the nerve path.
  • Clinical symptoms matching lesions seen on MRI.
  • Radicular pain lasting three months or more.
  • Normal or abnormal electromyogram (EMG) results.
  • Neuropathic pain confirmed by DN4 questionnaire.
  • Positive previous diagnostic nerve block.
  • Signed informed consent form.
Not Eligible

You will not qualify if you...

  • Patients under 18 years of age.
  • Low back pain not caused by nerve root problems.
  • MRI findings not matching symptoms.
  • Peripheral neuropathy in the legs.
  • History or current serious mental disorders.
  • Moderate or severe cognitive impairment or acute confusional state.
  • Infection at the treatment site.
  • Blood clotting problems.
  • Pregnant women.
  • Refusal to sign informed consent.
  • Allergy to radiological contrast dye.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Consorci Sanitari de Terrassa

Terrassa, Barcelona, Spain, 08227

Actively Recruiting

Loading map...

Research Team

M

Maria Martinez

CONTACT

M

Maria Martinez

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here